| |
| |
|
| Insider
Information: |
Viking Long Fund Gp Llc |
| Relationship: |
|
| City: |
Greenwich |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,020,407 |
|
|
Indirect Shares
|
157,545,325 |
|
|
| Direct
Value |
$5,316,320 |
|
|
|
Indirect Value
|
$1,266,600,614 |
|
|
| Total
Shares |
158,565,732 |
|
|
| Total
Value |
$1,271,916,935 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 4.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Editas Medicine, Inc. |
EDIT |
10% Owner |
2016-02-08 |
1,020,407 |
2016-02-08 |
1,020,407 |
Premium* |
|
|
Tekmira Pharmaceuticals Corp |
TKMR |
10% Owner |
|
0 |
2016-07-08 |
16,013,540 |
Premium* |
|
|
Sio Gene Therapies Inc |
SIOX |
10% Owner |
|
0 |
2018-06-05 |
89,285,714 |
Premium* |
|
|
Myovant Sciences Ltd. |
MYOV |
10% Owner |
2018-04-02 |
0 |
2018-04-02 |
38,341,357 |
Premium* |
|
|
Roivant Sciences Ltd. |
ROIV |
|
|
0 |
2023-06-22 |
12,884,307 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ROIV |
Roivant Sciences Ltd. |
|
• • • |
2023-06-22 |
4 |
S |
$9.90 |
$128,700,000 |
I/I |
(13,000,000) |
12,884,307 |
0 |
% |
|
| ROIV |
Roivant Sciences Ltd. |
|
– – • |
2021-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
88,238,700 |
|
- |
|
| SIOX |
Sio Gene Therapies Inc |
10% Owner |
– – • |
2018-06-05 |
4 |
B |
$1.75 |
$25,000,000 |
I/I |
14,285,714 |
89,285,714 |
1.5 |
- |
|
| MYOV |
Myovant Sciences Ltd. |
10% Owner |
– – • |
2018-04-02 |
4 |
B |
$20.27 |
$22,500,004 |
I/I |
1,110,015 |
38,341,357 |
1.5 |
- |
|
| TKMR |
Tekmira Pharmaceuticals C... |
10% Owner |
– – • |
2016-07-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
16,013,540 |
|
- |
|
| SIOX |
Sio Gene Therapies Inc |
10% Owner |
– – • |
2016-07-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
75,000,000 |
|
- |
|
| EDIT |
Editas Medicine, Inc. |
10% Owner |
– – • |
2016-02-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,020,407 |
|
- |
|
| EDIT |
Editas Medicine, Inc. |
10% Owner |
– – • |
2016-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,020,407 |
|
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
